Singapore - English - HSA (Health Sciences Authority)

sato pharmaceutical (singapore) pte ltd - guaifenesin; noscapine hcl - syrup - 300 mg/30 ml - guaifenesin 300 mg/30 ml; noscapine hcl 60 mg/30 ml

Singapore - English - HSA (Health Sciences Authority)

sato pharmaceutical (singapore) pte ltd - apricot kernel extract; glycyrrhiza extract; noscapine - lozenge - 60 mg - apricot kernel extract 60 mg; glycyrrhiza extract 125 mg; noscapine 60 mg

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

"kpe" zdorovje narodu" llc - morphine (morphine hydrochloride), noscapine, papaverine (papaverine hydrochloride), codeine, thebaine - solution for injection - 11,5mg/ml+ 5.4mg/ml+ 0.72mg/ml+ 1.44mg/ml+ 0,1mg/ml

Ireland - English - HPRA (Health Products Regulatory Authority)

sanofi-synthelabo ireland ltd - paracetamol noscapine phenylephrine - tablets

Ireland - English - HPRA (Health Products Regulatory Authority)

actavis uk limited - paracetamol phenylephrine noscapine ascorbic acid - tablets

India - English - Central Drugs Standard Control Organization

acron ph. - ethyl morphine hcl.,noscapine,ephedrine hcl.,chlorpheniramine maleate - tab - 7.5,7.5,10,2.5;mg - 10

India - English - Central Drugs Standard Control Organization

inga - amm.chl.,chlorpheniramine maleate,sod.cit.,menthol,sy.tolu,noscapine - syr - 100mg,2mg,50mg,1mg,2ml,7.5mg - 100ml

Israel - English - Ministry of Health

rafa laboratories ltd - buprenorphine - patches matrix - buprenorphine 5 mg - oripavine derivatives - treatment of moderate to severe opioid responsive chronic pain conditions which are not adequately responding to non-opioid analgesics.

Israel - English - Ministry of Health

rafa laboratories ltd - buprenorphine - patches matrix - buprenorphine 10 mg - oripavine derivatives - treatment of moderate to severe opioid responsive chronic pain conditions which are not adequately responding to non-opioid analgesics.

Israel - English - Ministry of Health

rafa laboratories ltd - buprenorphine - patches matrix - buprenorphine 20 mg - oripavine derivatives - treatment of moderate to severe opioid responsive chronic pain conditions which are not adequately responding to non-opioid analgesics.